Araştırma Makalesi

Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats

Cilt: 20 Sayı: 1 29 Haziran 2020
PDF İndir
EN

Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats

Abstract

Apilarnil is a bee product that has attracted attention due to its beneficial biological properties recently. This study aimed to investigate the effect of apilarnil (API) on endotoxin-induced lung injury. For the study, 64 adult male Sprague dawley rats were divided into eight groups; control, 0.2, 0.4 and 0.8 g / kg API treated groups by gavage for 10 days, 30 mg / kg lipopolysaccharide (LPS) administered intraperitoneally (single dose), LPS + 0.2, LPS + 0.4 and LPS + 0.8 g / kg API applied groups. In histopathological evaluation, hyperemia, intra-alveolar hemorrhage, cellular infiltration, and increased cellular abnormal proliferation were observed in the lung samples of the LPS group. It was found that the lung samples of LPS + 0,4 and LPS + 0,8 API groups decreased statistically significant compared to the LPS group. The number of TUNEL positive cells observed in both LPS and API treated groups showed a statistically significant decrease compared to the LPS group. In comet test, 0,8 API group was found to be reduced more in tail % DNA and tail length when LPS + API treated groups were compared with LPS group. In conclusion, the API applied to rats can prevent LPS-induced lung injury.

Keywords

Kaynakça

  1. 1 KAUKONEN, K M; BAILEY, M; SUZUKI, S, PILCHER, D; BELLOMO, R (2014), Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012, JAMA, 311(13), 1308-1316.
  2. 2 GYAWALI, B; RAMAKRISHNA, K; DHAMOON, A S (2019), Sepsis: The evolution in definition, pathophysiology, and management, SAGE Open Med, 7, 2050312119835043.
  3. 3 LEVY, M M; ARTIGAS, A; PHILLIPS, G S; RHODES, A; BEALE, R; OSBORN, T; VINCENT, J L; TOWNSEND, S; LEMESHOW, S; DELLINGER, R P (2012), Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, Lancet Infect Dis, 12(12):919-24.
  4. 4 POLAT, G; UGAN, R A; CADIRCI, E; HALICI, Z (2017), Sepsis and Septic Shock: Current Treatment Strategies and New Approaches, Eurasian J Med, 49(1):53-58.
  5. 5 ADAM, N; KANDELMAN, S; MANTZ, J; CHRETIEN, F; SHARSHAR, T (2013), Sepsis-induced brain dysfunction, Expert Rev Anti Infect Ther, 11(2): 211-21.
  6. 6 COHEN, J (2002), The immunopathogenesis of sepsis, Nature, 420: 885-91.
  7. 7 NDUKA, O O; PARRILLO, J E (2009), The pathophysiology of septic shock, Crit Care Clin, 25, 677-702, vii.
  8. 8 CINEL, I; OPAL, S M (2009), Molecular biology of inflammation and sepsis: a primer, Crit Care Med, 37: 291-304.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Yapısal Biyoloji , Ziraat Mühendisliği

Bölüm

Araştırma Makalesi

Yazarlar

Emin Kaymak Bu kişi benim
Andorra

Aslı Okan
Türkiye

Yayımlanma Tarihi

29 Haziran 2020

Gönderilme Tarihi

30 Ekim 2019

Kabul Tarihi

26 Haziran 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 20 Sayı: 1

Kaynak Göster

APA
Doğanyiğit, Z., Kaymak, E., Okan, A., Pandır, D., & Silici, S. (2020). Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats. Mellifera, 20(1), 3-15. https://izlik.org/JA46DK29FZ
AMA
1.Doğanyiğit Z, Kaymak E, Okan A, Pandır D, Silici S. Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats. mellifera. 2020;20(1):3-15. https://izlik.org/JA46DK29FZ
Chicago
Doğanyiğit, Züleyha, Emin Kaymak, Aslı Okan, Dilek Pandır, ve Sibel Silici. 2020. “Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats”. Mellifera 20 (1): 3-15. https://izlik.org/JA46DK29FZ.
EndNote
Doğanyiğit Z, Kaymak E, Okan A, Pandır D, Silici S (01 Haziran 2020) Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats. Mellifera 20 1 3–15.
IEEE
[1]Z. Doğanyiğit, E. Kaymak, A. Okan, D. Pandır, ve S. Silici, “Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats”, mellifera, c. 20, sy 1, ss. 3–15, Haz. 2020, [çevrimiçi]. Erişim adresi: https://izlik.org/JA46DK29FZ
ISNAD
Doğanyiğit, Züleyha - Kaymak, Emin - Okan, Aslı - Pandır, Dilek - Silici, Sibel. “Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats”. Mellifera 20/1 (01 Haziran 2020): 3-15. https://izlik.org/JA46DK29FZ.
JAMA
1.Doğanyiğit Z, Kaymak E, Okan A, Pandır D, Silici S. Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats. mellifera. 2020;20:3–15.
MLA
Doğanyiğit, Züleyha, vd. “Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats”. Mellifera, c. 20, sy 1, Haziran 2020, ss. 3-15, https://izlik.org/JA46DK29FZ.
Vancouver
1.Züleyha Doğanyiğit, Emin Kaymak, Aslı Okan, Dilek Pandır, Sibel Silici. Investigation of Protective Effects of Apilarnil Against Lipopolysaccharide Induced Lung Injury in Rats. mellifera [Internet]. 01 Haziran 2020;20(1):3-15. Erişim adresi: https://izlik.org/JA46DK29FZ